About Polycomb group RING finger protein 6
Polycomb group RING finger protein 6 (PCGF6) is a protein
from Homo sapiens identified by UniProt accession
Q9BYE7, 350 residues long.
MolForge cross-references it against 0 known binders and
30 disease associations.
Target properties
| Protein name | Polycomb group RING finger protein 6 |
| UniProt accession | Q9BYE7 |
| Gene | PCGF6 |
| Organism | Homo sapiens |
| Length | 350 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (30)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.36
- cortical surface area measurement · score 0.10
- body height · score 0.09
- thalamus volume · score 0.06
- mean corpuscular volume · score 0.06
- brain volume measurement · score 0.04
- glomerular filtration rate · score 0.04
- autosomal dominant spondylocostal dysostosis · score 0.04
- intracranial volume measurement · score 0.04
- autosomal recessive spondylocostal dysostosis · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BYE7-F1 | alphafold | PREDICTED | 71.97 | — |
Amino-acid sequence (350 residues)
MEGVAVVTAG SVGAAKTEGA AALPPPPPVS PPALTPAPAA GEEGPAPLSE TGAPGCSGSR PPELEPERSL GRFRGRFEDE DEELEEEEEL EEEEEEEEED MSHFSLRLEG GRQDSEDEEE RLINLSELTP YILCSICKGY LIDATTITEC LHTFCKSCIV RHFYYSNRCP KCNIVVHQTQ PLYNIRLDRQ LQDIVYKLVI NLEEREKKQM HDFYKERGLE VPKPAVPQPV PSSKGRSKKV LESVFRIPPE LDMSLLLEFI GANEGTGHFK PLEKKFVRVS GEATIGHVEK FLRRKMGLDP ACQVDIICGD HLLEQYQTLR EIRRAIGDAA MQDGLLVLHY GLVVSPLKIT
Explore Polycomb group RING finger protein 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets